The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

DEAR DR. ROACH: I am a 53-year-old healthy male, and I always request to check my PSA levels each year. My 57-year-old brother’s new doctor denied his request for a routine PSA check on their initial ...

The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy ...

NEW YORK (Reuters Health) - Most older men with prostate cancer found by prostate-specific antigen (PSA) tests and biopsies opted for treatment in a new study - even if signs pointed to their disease ...

Following an initial PSA test result of 3.0-19.99 ng/mL in men aged 50-70 years, a repeat PSA test within seven weeks allows for more accurate assessment as to whether a biopsy will reveal prostate ...

Men with a normal PSA upon repeat testing had a 78% lower risk of prostate cancer diagnosis than men with a second abnormal PSA result. For men with an elevated PSA, re-testing PSA levels within a ...

ATLANTA - Each year, millions of American men get a blood test known as a PSA, or prostate-specific antigen, test as part of their yearly checkup. PSA is a protein produced by the prostate gland. If a ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

A urine test could have avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study that included more than 1,500 ...

However, the UK National Screening Committee (UKNSC) has announced its draft decision to advise the government against ...